Real-world pharmacokinetics of ramucirumab in combination with erlotinib and docetaxel for advanced non-small cell lung cancer: a prospective cohort study
NEF2L2 rs35652124C>T Polymorphism Predicts Grade 4 Neutropenia in Esophageal Cancer Patients Treated with Docetaxel, Cisplatin, and Fluorouracil Chemotherapy: Results from Exploratory and Validation Cohorts
Drug–drug interactions with pioglitazone, losartan, and midazolam and anti-tumor efficacy and safety study of TAS- 115 in patients with solid tumors
RNA processing kinase inhibitors and epigenetic inhibitors in combination with oncology drugs or investigational agents in multi-cell type patient-derived tumor cell line spheroids
Novel Desensitization Protocol Utilizing Conventional Formulations to Mitigate Temozolomide-Related Skin Hypersensitivity
Pharmacokinetic Profile of Novel Reduced-Dose Danziten™ (Nilotinib Tablets) versus Tasigna® (Nilotinib Capsules): In Vivo Bioequivalence and Population Pharmacokinetic Analysis
Evaluation of urinary vanin-1 for the early prediction of cisplatin-induced acute kidney injury during neoadjuvant chemotherapy for esophageal cancer
A Phase I Study of MLN4924 and Belinostat in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
HER-2 SMASH
Pharmacokinetics, mass balance, and metabolism of [14C]PLB1004, a selective and irreversible EGFR-TKI in humans
Learn more about Cancer Chemotherapy and Pharmacology